Mibelle Biochemistry unveils anti-ageing snow algae extract

By Andrew MCDOUGALL contact

- Last updated on GMT

An extract of snow algae can protect the skin against environmental stress factors and improve the barrier function and has been developed by Mibelle Biochemistry. Here, Dr Fred Zülli gives Cosmetics Design an exclusive insight.

Snow algae grows in mountain areas in spring time in a green form and then turns red when there is too much UV-irradiation and a lack of nutrients on the glaciers.

The Buchs-headquartered company has harnessed this phenomenon and plans to launch its novel active at in-cosmetics in Hamburg on April 1-3, 2014.

Zülli explains that Mibelle Biochemistry has developed a biotechnological process to grow this algae in glass tube reactors, with the cells then harvested and extracted for cosmetic use.

This has uncovered a new anti-ageing activity with this snow algae extract based on a caloric restriction mimetic anti-ageing activity, which has been shown to significantly extend the life span of organisms.

“We could show that our snow algae extract can stimulate the longevity gene Klotho and the energy sensor protein AMPK and therefore induce a caloric restriction mimetic effect in skin cells,”​ says Zülli. “That means we get anti-aging effects without diet and exercise.”

Related news

Show more

Related products

show more

The first Exposome-Proof Natural Skin Brightener

The first Exposome-Proof Natural Skin Brightener

Symrise | 20-Oct-2017 | Product Brochure

Time has come to take a new look on pigmentation disorders. UV has long been identified as the main cause for aging and darks spots. But recent research...

SymDiol® 68 a smart synergistic protectant

SymDiol® 68 a smart synergistic protectant

Symrise | 09-Oct-2017 | Product Brochure

Today, cosmetic formulators face an increasingly challenging task to protect formulations and at the same time answering consumers’ desires for less preservatives...

AprinnovaSqualaneBrochure-610x343

Neossance® Squalane, Skin Therapy Benefits

APRINNOVA – A joint venture of AMYRIS and NIKKOL Group | 26-Sep-2017 | Clinical Study

Aprinnova is leading a resurgence in Squalane, reducing supply fears while making it attractive to use in mass/value positioned brands. Aprinnova is addressing...

Related suppliers